News and Announcements
Alcidion’s Intelligent Cardiovascular Information System (iCVIS) to be Delivered to Sunshine Coast University Hospital Through FUJIFILM
- Published June 06, 2016 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
3rd June 2016, ASX Announcement
Highlights:
- Strengthening of the commercialisation of iCVIS through FUJIFILM.
- Contract to deliver iCVIS to Sunshine Cost University Hospital.
- Cardiovascular Information System market estimated to be $USD917m by 2020.
FUJIFILM Medical Systems, a division of FUJIFILM Australia Pty Ltd (FUJIFILM), has secured a contract to deliver a leading edge intelligent cardiovascular Information System (iCVIS) to the Sunshine Coast University Hospital in Queensland, Australia. iCVIS was developed by Alcidion for FUJIFILM and is built upon the Miya platform to address clinical rick, workflow and logistic issues that are encountered in cardiology labs. The terms of the transaction remain commercial-in-confidence.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
